Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion

NCT07002476 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT07002476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07002476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion
Lead sponsor
Shanghai East Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
June 19, 2025
Completion date
June 1, 2027
Enrollment
978 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke